Radionetics Oncology represented by Paul Grayson and Brett Ewald participate in Fireside Chat hosted by Truist Securities
Radionetics Oncology’s Post
More Relevant Posts
-
Satej Bhogill and Catherine Chintala, PMP share what they enjoyed most at this year's #ASCO24 conference. Learn more about MERIT's oncology experience and solutions at https://lnkd.in/gD7rC9zQ #MERITCRO #YourClinicalEndpointExpert #imagingsolutions #clinicaltrials #clincialresearch #oncologytrials
-
Review what was discussed at the 2023 Precision Oncology Forum in regards to best practices & challenges involved in building an effective precision oncology program, by Jazieh et al. https://lnkd.in/gMk-HKtf #precisiononcology #JIPO
-
-
Hello Boston. Translational Drug Development (TD2) is at Clinical Trials in Oncology East Coast. Visit our booth and learn how TD2 can help advance your cancer therapeutic program (from bench to bedside). While I won't be there (why did I hear a huge sigh of relief 😉), my colleague Parris Johnson is the man you want to speak with anyway. Don't worry, I'll be back for Tumor Models Boston in a couple weeks. #clinicaltrials #cancertherapeutic #oncology #tumormodelsboston #tumormodels #clinicaldevelopment #preclinical
Today's the day, TD2 is live in Boston at Clinical Trials in Oncology East Coast! Stop by to learn about our latest advancements in oncology research or follow the link to schedule a meeting: https://hubs.li/Q02FhSPg0
-
-
Are you aware of the recent implementation of the EU Clinical Trials Regulation No 536/2014 and how that will affect your oncology program? Find out in my team members’ blog: https://bit.ly/3Yws1UO
-
-
Medical Director | Medical Affairs | Physician Consultant | Cell & Gene Therapy Advisor | Drug Safety Physician — Hematology, Oncology & Rare Diseases
Are you aware of the recent implementation of the EU Clinical Trials Regulation No 536/2014 and how that will affect your oncology program? Find out in my team members’ blog: Navigating the Complex Regulatory CRO Landscape for Oncology Trials in the EU https://bit.ly/3WEcxga
-
-
Are you aware of the recent implementation of the EU Clinical Trials Regulation No 536/2014 and how that will affect your oncology program? Find out in my team members’ blog: https://bit.ly/4d8eHdy
-
-
Hear from Simone Ndujiuba, PharmD, BCOP as she discusses the difference between oncology case management and navigation in the latest Oncology Insights. Learn more: https://bit.ly/4hXMs4q
-
Explore this case study and find out how a tailored solution gave a global oncology program the head start it needed. https://lnkd.in/d-ukwxEm
-
The latest news in oncology, including insights on notable Multiple Myeloma NCCN Guideline updates from chair of the guidelines Shaji Kumar, MD, can be viewed in my weekly newsletter here: https://bit.ly/48TnOOb
-
